CounterAct
- Product NDC
- 54473-305
- 11-digit product format
- 544730305
- Labeler code
- 54473
- Product ID
- 54473-305_30ce656f-cab7-9520-e063-6294a90a43ff
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Melaleuca, Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-05-02
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 54473-305-50 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 54473-305-50 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 54473-305-50 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CounterAct
- Brand name suffix
- Pain
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54473-305-50 | 2025-03-21 | C162847 | 48780-1 | 2cef2736-aae7-d83d-e063-dadaa90ab31f | CounterAct Pain Content of Labeling |
| 54473-305-50 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-aae7-d83d-e063-dadaa90ab31f | CounterAct Pain Content of Labeling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54473-305-50 | CounterActPain | 50 in 1 BOTTLE | TABLET, FILM COATED | 50 | 3 | |
| 54473-305-50 | CounterActPain | 1 in 1 BOX | TABLET, FILM COATED | 1 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Publix Fast Relief Effervescent | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Publix Super Markets Inc. | 73051f16-2569-7394-e053-2991aa0a5359 | 2024-11-13 | Warnings | M013 |
| Quality Choice Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Chain Drug Marketing Association | 70d265de-ff94-e0e4-e053-2a91aa0a962a | 2024-11-13 | Warnings | M013 |
| Quality Choice Extra Strength Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Chain Drug Marketing Association | 9f7d0c96-a561-a8a0-e053-2995a90a250b | 2024-11-13 | Warnings | M013 |
| WinCo Foods Effervescent Antacid and Pain Relief | ASPIRIN, SODIUM BICARBONATE, CITRIC ACID TABLET | WinCo Foods, LLC | 0c8a755a-089f-477f-97e9-0dd6fdfbe99d | 2024-11-13 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Kroger Company | 8fb19444-f0e0-4d26-81e8-6a4b835056d8 | 2024-11-12 | Warnings | M013 |
| pain and fever | ACETAMINOPHEN | Kroger Company | d181560c-1c39-4f2e-8a17-996224ca040f | 2024-11-09 | Warnings | M013 |
| Childrens Tylenol | ACETAMINOPHEN | Kenvue Brands LLC | babcb210-6a47-46ef-b4ea-bdde80411cd3 | 2024-11-08 | Warnings | M013 |
| Bayer Genuine Aspirin | ASPIRIN | Acme United Corporation | f7f9dc46-a945-7ae3-e053-6394a90a1192 | 2024-11-08 | Warnings | M013 |
| TYLENOL Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | dd87e342-b0cb-4111-9f15-415dbcda4b77 | 2024-11-07 | Warnings | M013 |
| Tylenol Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | 0c5fdda8-5049-46de-e063-6294a90a592b | 2024-11-07 | Warnings | M013 |
| Childrens TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | 46ddbfde-54ab-4373-b832-b9c0620b1e9d | 2024-11-07 | Warnings | M013 |
| Childrens TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | 333f6231-3778-4c1f-9558-2afddca22c86 | 2024-11-07 | Warnings | M013 |
| Childrens TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | 34247a3b-0846-4086-becd-76e630b3b721 | 2024-11-07 | Warnings | M013 |
| Childrens TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | a51c2deb-c703-4dc8-9255-8ac9fe635170 | 2024-11-07 | Warnings | M013 |
| Childrens TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | ce0a1fbc-7345-462b-b0da-c7149bdc288c | 2024-11-07 | Warnings | M013 |
| TYLENOL Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | 015a6179-bacb-452d-b594-4de628ddc11d | 2024-11-07 | Warnings | M013 |
| TYLENOL Regular Strength | ACETAMINOPHEN | Kenvue Brands LLC | de5c6654-56c5-40d3-a286-f04ed47ac7c8 | 2024-11-07 | Warnings | M013 |
| Midol Complete | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Acme United Corporation | f7bf126d-a6f1-231a-e053-6294a90a04e1 | 2024-11-07 | Warnings | M013 |
| CareOne Childrens Acetaminophen | ACETAMINOPHEN | American Sales Company | 49021ae8-9655-4885-9f74-52df4cdcb26f | 2024-11-07 | Warnings | M013 |
| aspirin | ASPIRIN | A-S Medication Solutions | 65c41c20-2f9c-4012-900b-c2ffdf665144 | 2024-11-06 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | CounterAct Pain 500 MG Oral Tablet | PSN | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | acetaminophen 500 MG Oral Tablet [CounterAct Pain] | SBD | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 198440 | APAP 500 MG Oral Tablet | SY | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | APAP 500 MG Oral Tablet [CounterAct Pain] | SY | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | CounterAct Pain 500 MG Oral Tablet | SY | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 54473-305-50 | 54473030550 | 1 BOTTLE in 1 BOX (54473-305-50) / 50 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2018-01-01 | 0000-00-00 | No | No | Current |